Global Human Prothrombin Complex Concentrate Market Growth 2023-2029

Global Human Prothrombin Complex Concentrate Market Growth 2023-2029

The global Human Prothrombin Complex Concentrate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Human Prothrombin Complex Concentrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Human Prothrombin Complex Concentrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Human Prothrombin Complex Concentrate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Human Prothrombin Complex Concentrate players cover Octapharma, CSL, Beijing Tiantan Biological Products Co., Ltd., Shanghai RAAS, Biotest, Thailand Bio, Hualan Bio, Weiguang Biology and Green Cross (China) Biological Products Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Human prothrombin complex concentrate, also known as factor IX complex, is a plasma-derived coagulation factor extract, which was originally used to treat factor IX deficiency, because PCC also contains coagulation factors II, VII, and X, so PCCs are more commonly used Recommended for correcting coagulation abnormalities caused by warfarin. It is mainly used for the treatment of congenital and acquired coagulation factor II, VII, IX, and X deficiency (single or combined deficiency).

LPI (LP Information)' newest research report, the “Human Prothrombin Complex Concentrate Industry Forecast” looks at past sales and reviews total world Human Prothrombin Complex Concentrate sales in 2022, providing a comprehensive analysis by region and market sector of projected Human Prothrombin Complex Concentrate sales for 2023 through 2029. With Human Prothrombin Complex Concentrate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Human Prothrombin Complex Concentrate industry.

This Insight Report provides a comprehensive analysis of the global Human Prothrombin Complex Concentrate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Human Prothrombin Complex Concentrate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Human Prothrombin Complex Concentrate market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Human Prothrombin Complex Concentrate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Human Prothrombin Complex Concentrate.

This report presents a comprehensive overview, market shares, and growth opportunities of Human Prothrombin Complex Concentrate market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
500 IU
1000 IU

Segmentation by application
Hemophilia B
Vitamin K Deficiency
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Octapharma
CSL
Beijing Tiantan Biological Products Co., Ltd.
Shanghai RAAS
Biotest
Thailand Bio
Hualan Bio
Weiguang Biology
Green Cross (China) Biological Products Co., Ltd.
Beijing Bohui Innovative Biotechnology Group Co., Ltd.
Guangdong Shuanglin Biopharmaceutical Co., Ltd.
Jiangxi Boya Biopharmaceutical Co., Ltd.
Takeda
Grifols
Shanghai Emerging Pharmaceuticals

Key Questions Addressed in this Report

What is the 10-year outlook for the global Human Prothrombin Complex Concentrate market?

What factors are driving Human Prothrombin Complex Concentrate market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Human Prothrombin Complex Concentrate market opportunities vary by end market size?

How does Human Prothrombin Complex Concentrate break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.